Point72 Asset Management
AVXL icon

Point72 Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Point72 Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-222,300
Closed -$2.07M – 2171
2023
Q4 		$2.07M Buy
+222,300
New +$1.53M 0.01% 1194

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management's AVXL Position: Q2 2026 in Review

Point72 Asset Management opened a new position in Anavex Life Sciences (AVXL) in Q2 2026: 157,486 shares worth $408K. The stake represents ﹤0.01% of the portfolio and ranks #3267 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in AVXL as recently as Q4 2025.

Point72 Asset Management first reported a position in AVXL in Q4 2025 and has held it in 2 quarters since. The position peaked at $990K in Q4 2025. 180 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Point72 Asset Management held 157,486 shares of Anavex Life Sciences worth $408K as of Q2 2026.
  • Anavex Life Sciences was a new Point72 Asset Management position in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #3267 holding.
  • Point72 Asset Management first reported a position in Anavex Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • Point72 Asset Management's Anavex Life Sciences position peaked at $990K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.